CDH1 and renal carcinoma: Surprisingly, a most recent report shows that MALAT1 promotes the activation of PRC2 by binding to EZH2 and enhances EZH2-mediated repression of Polycomb-dependent target gene E-Cadherin in clear renal cancer [19].